+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Phenotypic analysis of PBMCs from uterine cervix cancer patients with high natural killer activity



Phenotypic analysis of PBMCs from uterine cervix cancer patients with high natural killer activity



Journal of Clinical and Laboratory Immunology 49(2): 83-89



Phenotypic analysis of peripheral blood mononuclear cells from uterine cervix cancer patients, with increased natural killer cell activity, treated with radiation therapy was carried out. An increase in the percentage of CD56+ cells was observed in 5 out of 7 patients. When the expression of CD69, a phenotypic marker of cellular activation, was analyzed in 6 patients, an increase was observed in 4 of them. No direct correlation between cytolytic activity and the levels of CD56+ or CD69+ cells were observed. After 72 hr, an increased expression of CD56 was observed in 3 patients and a similar picture was seen at the same time following activation with IL-2 or IFN.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046973786

Download citation: RISBibTeXText

PMID: 9819676


Related references

Increased natural killer cell activity in uterine cervix cancer patients undergoing radiation therapy. Natural Immunity 14(4): 216-224, 1995

Increased natural killer cells activity in uterine cervix cancer patients undergoing radiation therapy. Natural Immunity 14(4): 216-224, 1995 ( ), 1996

Natural killer cell activity in patients with abnormalities of the uterine cervix. Gynecologic and Obstetric Investigation 18(3): 122-128, 1984

Analysis of natural killer activity and natural killer cell subsets in patients with bladder cancer. Cancer Immunology Immunotherapy 32(3): 191-194, 1990

Phenotypic and functional analyses of natural killer cells: Impaired NK activity partly due to the CD56+ cell dysfunction in cancer patients. International Journal of Immunotherapy 15(1): 1-12, 1999

Clinical implications of natural killer (NK) cytotoxicity in patients with squamous cell carcinoma of the uterine cervix. Gynecologic Oncology 36(1): 90-92, 1990

Phenotypic and functional analysis at the clonal level of infiltrating T lymphocytes in papillary carcinoma of the thyroid: prevalence of cytolytic T cells with natural killer-like or lymphokine-activated killer activity. Journal of Clinical Endocrinology and Metabolism 69(4): 832-836, 1989

The studies of natural killer cell activity in uro-genital cancer patients--investigation of natural killer cell activity from the standpoint of stage and antitumor therapy of genito-urinary tract carcinomas. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 79(2): 239-245, 1988

Lung natural killer and interleukin-2 activity in lung cancer. A pulmonary compartment of augmented natural killer activity occurs in patients with bronchogenic carcinoma. American Review of Respiratory Disease 136(6): 1327-1332, 1987

Natural killer cell activity in gastrointestinal cancer patients--a decline in natural killer cell activity in T cells and the action of interferon on its increase. Nihon Gan Chiryo Gakkai Shi 16(7): 1371-1376, 1981

Mechanism of diminished natural killer activity in patients with acquired immunodeficiency syndromes localization of the natural killer defect in the trigger involved in the release of natural killer cytotoxic factors by the stimulator target. Natural Immunity & Cell Growth Regulation 4(5): 239, 1985

Phenotypic analysis and natural killer activity of human sinusoidal mononuclear cells. Tscuhiya, M, Yodoi, J, Hibi, T, Miura, S International Congress Series; Current topics in mucosal immunology, 1993 253-256, 1994

Analysis of environmental factors in patients with cancer of the uterine cervix and uterine body. Ginekologia Polska 40(11): 1245-1250, 1969

Controlled natural in vitro fertilization may be an alternative for patients with repeated unexplained implantation failure and a high uterine natural killer cell count. Fertility and Sterility 82(1): 234-236, 2004